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ABSTRACT 
Stargardt’s disease is a juvenile macular dystrophy which tends to appear between the ages of 10 to 20, 
although visual impairment may not be apparent until as late as ages 30 to 40.  Visual acuity including 
colour vision testing, visual field analysis, ERG, Fundus Fluorescein Angiography and Amsler grid charting 
are the useful diagnostic techniques for this disease. Even though significant research is taking place in this 
area, no treatment is available till date for this disease and general approach of macular degeneration is 
following now. In Ayurveda by considering the visual disturbance and field defect, this disease can be 
included under one the 12 types of Drishtigata rogas. Pitthavidagdhadrishti is one of the disease explained 
by Acharya Susrutha in Drishtirogas is more appropriate to define this clinical condition. As there is no 
common line of management following in these types of diseases in Ayurveda, an attempt has been made to 
explain a case treated as per the Ayurvedic principles. This article describes a30 year old male patient 
diagnosed as Stargardt’s macular degeneration and underwent Ayurvedic treatment protocol starting from 
the Snehapana and ending with Yogavasthi. By executing the Ayurvedic treatment, the quality of the vision 
mainly color perception including distant and near acuity is improved at least for a period of four years. 
The distant vision improved up to 6/24 and near vision N6 (P) in better eye.  The treatment methodology 
adopted in this case can be taken as a guideline to manage the macular degenerative diseases which need 
extensive management to tackle the pathology. 
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INTRODUCTION 
Stargardt’s disease (also called Stargardt’s 
macular degeneration or Stargardt’s macular dystrophy) is 
a rare inherited eye condition which affects the central 
area of the retina called the macula.[1] It is also sometimes 
called fundus flavimaculatus. It affects about 1 in 10,000 
people.[2] Stargardt’s disease is sometimes called a juvenile 
macular dystrophy since it tends to first appear between 
the ages of 10 to 20 although visual impairment may not 
be apparent until as late as ages 30 to 40. 
It is inherited as an autosomal recessive trait, 
which is a severe form of macular degeneration that starts 
late in childhood. Stargardt’s disease turns into macular 
degeneration, and it will eventually lead to legal blindness. 
This is different from macular degeneration found in older 
people, as it does not generally lead to blindness.[3] 
Stargardt’s disease was first diagnosed in 1901 by Karl 
Stargardt, a German ophthalmologist. It is one of several 
early onset, inherited macular degeneration diseases. 
AIMS AND OBJECTIVES  
 To study the efficacy of Ayurvedic management in 
Stargardt’s macular degeneration.  
 To understand Stargardt’s macular degeneration in 
Ayurvedic perspective. 
MATERIALS AND METHODS 
 A 30 year old male patient diagnosed as 
Stargardt’s macular degeneration was selected and 
consent was taken. 
 
 
Review of Literature 
A. Pathological considerations - Modern perspective 
 Retinal changes in Stargardt’s disease 
In Stargardt’s disease there are two main findings 
on the retina are commonly seen. In the initial stages, 
usually an oval-shaped lesion, often referred to as ‘beaten 
bronze’ in appearance, around the macula is seen. This 
lesion tends to deteriorate over time leads to a loss of 
visual acuity,  reduced colour perception and more 
discomfort in the day light or bright light vision. The 
second change involves yellowish flecks which surround 
this lesion. In some cases people have just these flecks 
without the macular lesion and this type of disease used to 
be diagnosed with fundus flavimaculatus.[4] However, 
some researchers believe that these two problems, the 
macular lesion and the yellow flecks, are both caused by 
the gene which causes Stargardt’s disease and therefore 
are different versions of the same genetic problem. It has 
also been suggested that fundus flavimaculatus and 
Stargardt’s disease vary in age of onset and severity where 
fundus flavimaculatus may appear in the 20’s and 30’s and 
vision may be more severely affected. 
 Consequences on vision in Stargardt’s disease 
Stargardt’s disease mainly affects the macula and 
hence central vision is affected more. So this disease will 
make the central vision unclear and then sometimes 
distorted or blurred. As the disease progresses, a blank 
patch may appear in the centre of vision (central scotoma). 
Stargardt’s disease does not affect other parts of the retina 
so does not normally affect peripheral or side vision. But 
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this can also cause problems such as glare and difficulties 
adapting to changing light conditions and colour 
perception. Stargardt’s disease does not appear to have 
any effect on general health.  
 Diagnostic techniques 
Usually the diagnosis is apparent from the history, 
age of manifestation and the way of presenting the visual 
related problems. Patients generally begin to lose the near 
vision in both eyes between the ages of 20 and 30. Initially 
the eyes may look normal, but as the years pass, the flecks 
and atrophic scars develop. A useful test is the fundus 
fluorescein angiogram (FFA) in which approximately 86% 
of the patients shows a sign called the “dark choroid effect” 
is present, which arises from the abnormal accumulation 
of the substance lipofuscin in the retinal pigment 
epithelium.[5] Monitoring the visual acuity (distant & near), 
colour vision, visual field analysis, ERG, Fundus 
Fluorescein Angiography and Amsler grid charting are the 
useful diagnostic techniques. 
 Prognosis and management  
There is currently no treatment for Stargardt’s 
disease in modern medicine. Researchers have reported 
that exposure to ultraviolet light may cause further retinal 
damage.  This is because an abnormal protein in retinal 
pigment epithelium (RPE) layer becomes more toxic when 
patient exposed to extreme sunlight. It is therefore 
recommended that wearing sunglasses with UV protection 
that conforms to Australian Standards and a hat with a 
wide brim can protect individuals from the sun’s damaging 
ultraviolet rays.[6] In general, the same dietary 
recommendations that are made for the age-related form 
of macular degeneration are usually apply to people with 
Stargardt’s disease. 
B. Pathological considerations - Ayurvedic perspective 
The features like central visual loss diminished 
distant and near vision are pointing towards the 
pathophysiology of Tritheeya Patala gata Thimira.[7] 
Similar Dosha vitiation is also mentioned in the 
pathophysiology of Pitthavidagdha drishti.[8] In this disease 
patient feels more difficulty during the day vision also. As 
the disease starts manifesting in the Tritheeya patala, 
special attention should be given to Raktha dhatu. Due to 
the involvement of deeper Dhatus, the prognosis is also 
become Yapya or Asadhya.Chakshu vaisheshika Alochaka 
Pittha and Prana vayu should be given distinct 
consideration while planning the treatment protocol.  
Panchakarma treatment along with Rasayana is 
needed to tackle this disease pathology. Snehapana, Nasya, 
Virechana and Basthi along with Tarpana are the potent 
treatment procedures found to be effective in this 
condition. 
CASE STUDY 
To report a patient with Stargardt’s disease 
treated with classical Ayurvedic management, a 30 year 
old man with Stargardt’s disease treated in our hospital 
participated in the study. Examinations performed before 
and after treatment including visual acuity, fundus 
photography, Amslergrid. FFA was done to confirm the 
diagnosis. 
30 year old patient who is computer professional 
approached our OPD on 04-10-12 with diminished distant 
and near vision in both eyes. He is also complained of glare 
during night driving and distortion of images especially 
during reading. His visual acuity at that time was 
4/60which improved to 6/60in both eyes and near vision 
N8OD and N10 OS with strain. Patient was diagnosed as a 
case of bilateral macular dystrophy previously. Patient 
gave a history of progressive loss of vision in both eyes and 
using glasses for that since 16 years of age. On 
ophthalmoscopic examination on 10-10-12 revealed 
degenerated macula with beaten bronze appearance with 
temporal pallor of optic disc bilaterally. On Amsler grid 
charting, central area was missing. FFA was done and 
showed ‘dark choroid effect’ in macular area in both eyes; 
all these are the characteristic features of Stargardt’s 
disease.[9] 
The patient was admitted in Govt. Ayurveda 
college hospital Tripunithura on 17-10-12and underwent 
Deepana Pachana for 05 days with Gandharvahasthadi 
Kashaya.[10] 90ml BD before food and Vaiswanara choorna 
[11] 15gm with hot water twice daily at 11AM and 5PM. 
After that Acchasnehapana was started with Patoladi 
ghrita[12] starting with a dose of 30 gm daily up to 180 gm 
on 7th day followed by Abhyanga with Ksheerabala taila[13] 
and Ooshma sweda for 03 days. Virechanakarma was done 
by Avipathy choorna[14] 30 gm with Draksha Phanta on 11th 
day. Total 15 Vegas observed and Samsarjanakrama was 
advised for 03 days. 
 From 15th day onwards, Marsha Nasya was done 
with Mahatriphalaghrita[15] 10 drops each nostril for 7 
days and after completion of Nasya from 22nd day onwards 
Tarpana with Shatahwadi ghrita[16] for 5 days for the 
duration of 15-20 minutes followed by Snehana putapaka 
made with Jeevaniyagana and Ajamamsa rasa for one day 
in the morning time. Shirodhara was given with 
Ksheerabala thaila for seven days for duration of 45 
minutes in the evening time. 30th day onwards, Yogavasthi 
was done at the end of the treatment protocol in which 
Madhuyashtyadi taila[17] is used for Asthapana and 
Erandamooladi kwatha[18], Patoladi ghrita and Mahatripha 
ghrita along with Madhuyashtyadi taila is used for Nirooha. 
The total treatment period was 38 days and 
during the follow-up period Pratimarsha Nasya with 
Mahatraiphala ghrita, Aschyotana with Jeevaniyagana 
ghrita[19] was administered. For oral intake Brahma-
rasayana[20] 15gm HS with Triphala choorna and 
Arogyavardhini Vati[21] 2BD also advised. 
Patient underwent regular IP treatment since last 
03 years and followed up for one year after the treatment. 
Last follow up was taken on 12-12-2016. Till date he was 
regularly taking the follow-up medicines and Netraroroga 
pathyakramas[22] mentioned in Ayurvedic classics. 
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Table 1: Showing Summary of the treatment given to the Patient 
No of Days treatment  medicine Dose and time duration 
 
Preparation 
Deepana Pachana 1. Gandharvahasthadi 
Kashaya 
2. Vaiswanara choorna 
90ml BD before food 
15gm with hot water twice 
daily at 11AM and 5PM 
 
05 days 
1-7 Acchasnehapana Patoladi ghrita 30-180gm early morning in 
empty stomach  
07 days 
8-10 Abhyanga & 
Ooshma sweda 
Ksheerabala taila 11 AM & 4 PM 03 days 
11 Virechana Avipathy choorna 30 gm with Draksha Phanta 
8AM 
01day 
(15 Vegas) 
12-14 Samsarjana Krama   03 days 
15-21 Marsha Nasya Mahatriphalaghrita 10 drops each nostril 7 days 
22-26 Tarpana Shatahwadi ghrita 15-20 minutes 5 days 
27 Snehana Putapaka 
 
Jeevaniyagana & 
Ajamamsa rasa 
10 minutes 01 day 
22-28 
(Simultaneously with 
Tarpana & Putapaka) 
Shirodhara 
(Moordhataila) 
Ksheerabala thaila 45 minutes at 4 PM 07 days 
30-38 Yogavasthi Madhuyashtyadi taila & 
Erandamooladi kwatha 
 08 days 
OBSERVATION AND RESULT 
During the last four years, the visual acuity was not deteriorated and patient felt more clarity of vision with slight 
improvement in the distant and near vision. The patient is using the computers without eye strain and the glare is relieved 
significantly.   
Table 2: Showing the visual acuity before & after treatments and after follow-up 
Investigation   Unaided Distant Aided Distant Unaided Near vision Aided  
Near vision 
OD OS OD OS OD OS OD OS 
 
Visual acuity 
B.T 4/60 4/60 6/60 6/60 N8 N10 N8 N8 
A.T 6/60 6/60 6/36 6/24(P) N8 N8 N8 N8 
After follow up 6/60 6/60 6/36 6/24 N8(P) N8 N8 N6(P) 
DISCUSSION  
By considering the pathophysiology and clinical 
features of Stargardt’s macular degeneration, it can be 
considered as a Dishtiroga in which utmost vitiation of 
Alochaka pittha. The Samprapthi and clinical features of 
Pitthavidagdha drishti is most suitable to understand this 
dangerous degenerative disease. Involvement of 
Sapthadhatus along with Vata-Pittha vitiation is the 
undergoing pathology in this case and Thrithiya patala is 
the site of lesion which is suddenly progressing to 
Chaturtha patala causing marked reduction of vision. Age 
of manifestation of the disease also points towards the role 
of Pittha in the disease process. 
While dealing such a chronic degenerative disease, 
ultimate line of management should be Vatapitthasamana 
and Rasayana.Patoladi ghrita was used for Snehapana due 
to its special indication in Pittha vidagdha drishti. For the 
Nasya purpose Ghrita form was selected for the 
Vatapitthashamana action and Mahatriphala ghrita has a 
special affinity towards improving the functions of 
Alochakapittha. For the purpose of Tarpana, Shatahwadi 
ghrita is used due to its Vatapradhana drishtirogahara 
action. Moordhataila has a special role here because 
Prnavayu plays a key role for the stimulation of 
Chakshurindriya. Ksheerabala taila has the affirmative 
effect of Vata-Pittha shaman and Indriyatarpana. 
After pacifying the Vata locally, by considering the 
chronic progressive nature of the disease, ultimate 
Vatashamana should be done in Pakvashaya, so that 
Yogavasthi is adopted here. In addition to this, yoga vasthi 
which is done also gives the additional effect of Rasyayana 
which is highly appreciated in this clinical condition. 
During follow-up period, Pratimarsha nasya, Ghrita 
Aschyotana and Rasayana were advised to get 
supplementary effect in due to its Chakshushya and 
Rasayana action. 
CONCLUSION 
Even though Stargardt’s macular degeneration is a 
chronic progressive disease; it can be managed by the 
principles of Ayurveda. By adopting the Ayurvedic 
treatment, the vision of the patient sustained and quality 
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of the vision including acuity is improved at least for a 
period of four years. So to manage the diseases like 
macular degenerations, an Ayurvedic treatment protocol 
should be derived so that more data can be generated. The 
method adopted in this case can be taken as a guideline to 
manage the macular degenerative diseases which need 
extensive management to tackle the pathology. 
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